Chris Shilling

Christopher Shilling has extensive experience in regulatory affairs and drug development, currently serving as the Chief Regulatory Officer and Senior Vice President of Regulatory Affairs at Forge Biologics since August 2020. Prior to this role, Christopher held various positions at Nationwide Children's Hospital from December 2005 to August 2020, including Director of Drug and Device Development and Research Program Manager. Christopher earned a Master’s degree in Pathology from The Ohio State University between 2001 and 2004.